Free shipping on all orders $250CAD or more within Canada.

KPV 10mg

KPV 10mg

SKU KP102607A

KPV is a short tripeptide composed of lysine, proline, and valineand corresponds to the C-terminal three-amino-acid sequence of alpha-melanocyte-stimulating hormone (α-MSH). It is primarily investigated for its potential role in inflammatory signaling, epithelial protection, immune regulation, and tissue-response pathways. Unlike full-length α-MSH, KPV retains substantial anti-inflammatory activity in experimental models while lacking its pigment-producing effect. Research has examined KPV in intestinal epithelial cells, immune cells, skin models, and airway epithelial systems, with particular interest in NF-κB and MAPK signaling. Experimental studies have also investigated its effects on pro-inflammatory cytokine production, oxidative stress, and cellular responses to inflammatory injury. Because of its very small three-amino-acid structure, KPV is useful for studying how minimal peptide sequences can retain specific biological signaling properties of larger parent peptides. Most evidence remains preclinical or mechanistic, and KPV has not been established as an approved therapeutic treatment. This material is intended for laboratory research only, is not authorized by Health Canada for human therapeutic use, and is not intended for human or veterinary administration.


CA$54.99

In Stock

Choose a kit option to save more, or skip this and buy individually above.

Save 8%
2 Vials x 10mg
CA$101.00 CA$110.00
Save 13%
4 Vials x 10mg
CA$191.50 CA$220.00
Save 20%
6 Vials x 10mg
CA$264.00 CA$330.00
Save 30%
10 Vials x 10mg
CA$385.00 CA$550.00
HPLC Purity Verified
Batch Documented
LC-MS Confirmation Available
2°C Storage

*LC-MS identity confirmation may be performed when analytical review indicates conflicting, atypical, or inconclusive results.

Overview

KPV, short for Lysine–Proline–Valine, is a synthetic tripeptide corresponding to residues 11–13 of alpha-melanocyte-stimulating hormone (α-MSH).

Its sequence is:

Lys – Pro – Val

or simply:

KPV

Despite consisting of only three amino acids, KPV has attracted considerable research interest because it retains much of the anti-inflammatory activity associated with α-MSH while lacking the pigmentary activity characteristic of the full peptide. PubMed

KPV is therefore commonly studied in experimental models involving:

  • inflammatory signaling;
  • intestinal epithelial biology;
  • immune-cell regulation;
  • skin inflammation;
  • oxidative stress;
  • airway inflammation;
  • cytokine production;
  • cellular stress responses.

The Three Components of KPV

Lysine — K

Lysine forms the N-terminal amino acid of the KPV sequence.

Lysine is a basic amino acid containing an additional positively charged amino group on its side chain under physiological conditions.

Within peptides, lysine can influence:

  • peptide charge;
  • molecular interactions;
  • protein binding;
  • membrane interactions;
  • enzymatic recognition.

In KPV, lysine contributes to the peptide's overall physicochemical character and may influence how the small peptide interacts with transport proteins and intracellular molecular targets.


Proline — P

Proline is structurally unusual among amino acids because its side chain loops back and bonds to its own amino nitrogen.

This cyclic structure restricts molecular flexibility and can influence peptide conformation.

Proline is frequently important in small bioactive peptides because it can:

  • impose structural rigidity;
  • alter peptide folding;
  • resist certain enzymatic cleavage patterns;
  • influence receptor or protein interactions.

Within KPV, proline helps create the compact structural geometry characteristic of the tripeptide.


Valine — V

Valine is a branched-chain amino acid and forms the C-terminal residue of KPV.

Its hydrophobic side chain contributes to molecular interactions involving nonpolar regions of proteins and cellular structures.

Within the KPV sequence, valine completes the minimal C-terminal fragment derived from α-MSH.

Together, lysine, proline, and valine form a remarkably small peptide capable of retaining biological effects associated with the much larger parent hormone.


Relationship to Alpha-MSH

Alpha-melanocyte-stimulating hormone is a peptide derived from the larger precursor protein proopiomelanocortin, or POMC.

α-MSH is associated with several biological processes, including:

  • melanocortin signaling;
  • inflammatory regulation;
  • immune-cell activity;
  • pigmentation;
  • neuroendocrine regulation.

Researchers discovered that the C-terminal KPV sequence retained substantial anti-inflammatory activity even though it lacked the full sequence required for α-MSH's pigmentary effects.

This finding made KPV especially interesting as a research model for separating the anti-inflammatory biology of α-MSH from its melanogenic actions. PubMed


Inflammatory Signaling Research

The primary area of KPV research is inflammatory regulation.

Experimental studies have shown that KPV can influence intracellular signaling pathways involved in inflammatory responses.

One important pathway is:

NF-κB

NF-κB is a transcription factor that regulates expression of numerous inflammatory genes.

When activated, NF-κB can increase production of inflammatory mediators and cytokines.

KPV has been shown in experimental systems to suppress NF-κB activation and reduce production of certain inflammatory signaling molecules. PubMed


MAPK Signaling Research

Another signaling system investigated with KPV is the MAP kinase pathway.

MAPK pathways help regulate cellular responses to:

  • stress;
  • inflammatory stimuli;
  • growth signals;
  • oxidative injury;
  • cytokines.

In intestinal epithelial and immune-cell studies, KPV has been associated with suppression of inflammatory MAPK signaling along with reductions in cytokine production. PubMed

This makes KPV useful for studying how short peptides can influence multiple inflammatory signaling pathways simultaneously.


Intestinal Research

One of the strongest areas of preclinical KPV research involves the intestinal epithelium.

The intestinal lining is constantly exposed to:

  • bacteria;
  • food-derived molecules;
  • microbial metabolites;
  • immune signals;
  • mechanical stress.

Maintaining controlled inflammatory signaling is therefore essential for intestinal homeostasis.

Laboratory research has investigated KPV in intestinal epithelial cells and experimental mouse models of colitis.

Studies have reported reductions in inflammatory signaling and pro-inflammatory cytokine expression in these models. PubMed


PepT1 Transport Research

A particularly interesting aspect of KPV biology involves the peptide transporter PepT1.

PepT1 normally transports small dipeptides and tripeptides across cellular membranes.

Researchers have demonstrated that KPV can be transported into intestinal epithelial and immune cells through PepT1.

This provides a useful mechanistic explanation for how such a small peptide may enter cells and influence intracellular signaling pathways.

Experimental studies found that PepT1-mediated KPV uptake was associated with inhibition of NF-κB and MAPK signaling. PubMed


Cytokine Research

Inflammatory responses rely heavily on signaling molecules known as cytokines.

KPV research has examined changes in several inflammatory mediators following cellular stimulation.

Experimental observations include reductions in signaling associated with:

  • inflammatory cytokine production;
  • chemokine secretion;
  • immune-cell activation;
  • inflammatory gene expression.

These effects appear to occur upstream at transcriptional and signaling levels rather than simply neutralizing one individual cytokine.


Skin and Keratinocyte Research

KPV has also been investigated in skin biology, particularly in keratinocytes.

Keratinocytes form the majority of the outer epidermis and play an active role in immune and inflammatory signaling.

Experimental studies have examined KPV in models involving:

  • inflammatory skin signaling;
  • oxidative stress;
  • environmental particulate exposure;
  • keratinocyte survival;
  • NF-κB activation;
  • cytokine production.

A 2025 keratinocyte study reported that KPV reduced oxidative-stress and inflammatory signaling in cells exposed to particulate matter, including effects involving reactive oxygen species and NF-κB-associated pathways. PubMed

These findings remain experimental and should not be interpreted as established clinical skin-treatment effects.


Oxidative Stress Research

Oxidative stress occurs when production of reactive oxygen species exceeds normal cellular antioxidant defenses.

Reactive oxygen species can activate inflammatory pathways and contribute to cellular injury.

KPV has therefore been studied in models examining the relationship between:

oxidative stress → inflammatory signaling → cellular injury

Experimental keratinocyte research has shown reductions in reactive oxygen species and associated inflammatory signaling under specific laboratory conditions. PubMed

This provides another potential mechanistic research application for KPV beyond conventional cytokine biology.


Airway Epithelial Research

KPV has also been studied in human bronchial epithelial cell models.

Research has examined its effect on inflammatory responses triggered by factors such as tumor necrosis factor and respiratory viral stimulation.

Observed experimental effects have included reductions in:

  • NF-κB activity;
  • IL-8 secretion;
  • eotaxin secretion;
  • matrix metalloproteinase activity.

Researchers also investigated KPV's interaction with intracellular nuclear transport mechanisms involved in NF-κB signaling. PubMed

This work helps illustrate that KPV's research applications are not confined exclusively to intestinal tissue.


Immune-Cell Research

KPV has been investigated in immune-cell systems because α-MSH-derived peptides are associated with regulation of inflammatory responses.

Potential areas of investigation include:

  • immune-cell activation;
  • inflammatory gene expression;
  • T-cell signaling;
  • cytokine secretion;
  • cellular migration.

The precise mechanism of KPV remains under investigation and does not appear to depend entirely on classical melanocortin-receptor signaling.

That distinction is important because KPV is substantially smaller than α-MSH and may interact with intracellular pathways differently. PubMed


Melanocortin-Receptor Research

Full-length α-MSH interacts with melanocortin receptors such as MC1R.

KPV, however, lacks much of the sequence normally associated with conventional melanocortin-receptor binding.

Research therefore suggests that at least some KPV activity may occur independently of classical α-MSH receptor signaling.

Studies in keratinocytes and inflammatory models have investigated alternative mechanisms involving:

  • intracellular calcium signaling;
  • peptide transport;
  • NF-κB regulation;
  • nuclear protein transport.

This remains an active mechanistic research area. PubMed


Antimicrobial Research

Early experimental research has also examined KPV in host-defense models.

Laboratory studies involving α-MSH and KPV reported inhibitory effects against organisms including Staphylococcus aureus and Candida albicans under experimental conditions. PubMed

These observations are mechanistic and laboratory-based.

They should not be interpreted as evidence that KPV is an approved antimicrobial treatment.

SpecificationDetails
Compound NameKPV
Full NameLysine–Proline–Valine
Alternative Nameα-MSH (11–13)
SequenceLys-Pro-Val
Sequence AbbreviationKPV
Chemical ClassSynthetic tripeptide
Nominal Strength10 mg per vial
Physical FormLyophilized powder
CAS Number67727-97-3
Molecular FormulaC₁₆H₃₀N₄O₄
Molecular WeightApproximately 342.43 g/mol
Research ClassificationInflammatory-signaling and epithelial-biology research peptide

PubChem identifies KPV as L-lysyl-L-prolyl-L-valine, molecular formula C₁₆H₃₀N₄O₄, molecular weight 342.43 g/mol, and CAS 67727-97-3. PubChem


Chemical Classification

KPV is a tripeptide, meaning it contains three amino-acid residues linked through peptide bonds.

Its sequence is:

H-Lys-Pro-Val-OH

The sequence corresponds to the C-terminal three residues of α-MSH.

Its small molecular size distinguishes it from many larger signaling peptides and makes it particularly useful for studying minimal bioactive peptide sequences. PubChem


Primary Research Areas

Inflammatory Signaling

Common research pathways include:

  • NF-κB signaling;
  • MAPK signaling;
  • inflammatory cytokines;
  • chemokines;
  • cellular inflammatory responses.

Intestinal Biology

Research applications include:

  • intestinal epithelial signaling;
  • PepT1 peptide transport;
  • experimental intestinal inflammation;
  • cytokine regulation;
  • mucosal cellular responses.

Skin Biology

Experimental applications include:

  • keratinocyte inflammation;
  • environmental oxidative stress;
  • cytokine signaling;
  • epidermal cellular responses.

Immune Research

Research interests may include:

  • immune-cell signaling;
  • inflammatory mediator production;
  • cytokine regulation;
  • cellular activation.

Airway Research

Experimental studies may evaluate:

  • bronchial epithelial inflammation;
  • NF-κB activity;
  • chemokine production;
  • inflammatory signaling.

Mechanism of Research Interest

A simplified experimental pathway can be represented as:

Inflammatory stimulus

↓

Cellular peptide uptake / signaling interaction

↓

NF-κB and MAPK pathway modulation

↓

Altered inflammatory gene expression

↓

Reduced inflammatory mediator production

Research indicates that several mechanisms may contribute, including peptide transport through PepT1 and intracellular effects on NF-κB-associated signaling. PubMed


Molecular Characteristics

Peptide length: 3 amino acids

Sequence: KPV

Full sequence: Lys-Pro-Val

Molecular formula: C₁₆H₃₀N₄O₄

Molecular weight: Approximately 342.43 g/mol

CAS number: 67727-97-3

Chemical class: Tripeptide

Nominal vial strength: 10 mg

Physical Presentation

Form: Lyophilized powder

Nominal content: 10 mg per vial

Compound type: Synthetic tripeptide

Primary research category: Inflammatory and epithelial signaling

Presentation: Research vial

Lyophilization is commonly used for research peptides to reduce water content and improve stability during appropriate storage before experimental preparation.


Solubility and Laboratory Preparation

KPV is a small peptide and is commonly handled in aqueous laboratory systems.

Specific solvent selection, concentration, pH, and preparation procedures should be determined by the experimental protocol.

Relevant variables may include:

  • solvent composition;
  • peptide concentration;
  • pH;
  • temperature;
  • storage duration;
  • freeze-thaw exposure;
  • assay conditions.

Consistency across these parameters is important when comparing experimental groups.


Storage and Handling

General laboratory handling considerations include:

  • maintain appropriate refrigerated storage where specified;
  • protect from excessive heat;
  • minimize prolonged moisture exposure;
  • reduce unnecessary light exposure;
  • avoid repeated temperature fluctuations;
  • use clean laboratory technique;
  • minimize contamination.

Experimental storage conditions should be standardized within each research protocol.


Research Model Applications

KPV may be relevant to laboratory investigations involving:

  • inflammatory signaling;
  • intestinal epithelial biology;
  • peptide transport;
  • immune-cell signaling;
  • keratinocyte research;
  • oxidative-stress models;
  • bronchial epithelial research;
  • cytokine production;
  • chemokine signaling;
  • NF-κB regulation;
  • MAPK signaling.

Experimental Endpoints

Researchers may examine endpoints such as:

Molecular Signaling

  • NF-κB activation;
  • MAPK activity;
  • inflammatory gene expression;
  • intracellular signaling proteins.

Cytokine Measurements

  • pro-inflammatory cytokines;
  • chemokines;
  • inflammatory mediator secretion.

Cellular Endpoints

  • cell viability;
  • oxidative stress;
  • reactive oxygen species;
  • epithelial responses;
  • inflammatory-cell activity.

Tissue-Level Endpoints

  • inflammatory infiltration;
  • epithelial integrity;
  • histological inflammatory changes;
  • cellular stress markers.

Intended Research Use

KPV 10 mg is intended for controlled laboratory investigation involving:

  • peptide biology;
  • inflammatory signaling;
  • intestinal research;
  • epithelial biology;
  • immune research;
  • skin-cell research;
  • oxidative-stress research;
  • airway epithelial research;
  • molecular signaling;
  • preclinical pharmacology.

Most evidence supporting these research areas comes from cellular and animal models, and experimental findings should not automatically be extrapolated to therapeutic outcomes in humans. PubMed


Regulatory Status

KPV remains an investigational research peptide.

It is not authorized by Health Canada for human or veterinary use and is intended strictly for laboratory and research purposes.

It is not intended for clinical, diagnostic, therapeutic, or veterinary administration.




TESTING METHODOLOGY

Each batch undergoes analytical review using validated laboratory procedures. HPLC testing is utilized to assess purity and compare the sample profile against established reference standards. Where additional verification is warranted, LC-MS analysis may be performed to support compound identity confirmation.

OUR ANALYTICAL VERIFICATION PROGRAM

  • Primary Testing: HPLC purity analysis and reference comparison
  • Identity Confirmation: LC-MS performed when indicated*
  • Quality Standards: Batch traceability, analytical documentation, third-party testing and storage procedures

*See LC-MS Confirmation Information for full details.

Every batch supplied by Vanguard Compound Research is assigned a unique batch number and maintained under documented quality-control procedures with supporting analytical documentation available upon request.

SHIPPING & FULFILLMENT

FULFILLMENT INFORMATION
Ships from Canada

All orders ship from within Canada.

Batch Documentation Available

Batch records and analytical documentation may be provided for qualifying products.

Secure Packaging

Products are packaged securely to ensure safe delivery.

Tracking Provided

Tracking information is provided for every shipment.

Temperature-Conscious Handling

Frozen or ambient-safe packaging used as appropriate.

All Vanguard Compound Research orders are shipped directly from within Canada, ensuring efficient delivery, reliable service, and consistent quality-control from fulfillment to arrival.

Canadian Researchers Benefit From:

  • Domestic shipping with no customs delays
  • Batch-specific third-party laboratory testing
  • Full lot number traceability on every product
  • Access to batch-specific Certificates of Analysis (COAs)
  • Dedicated customer support

Canada-Wide Fulfillment:

  • Orders processed Monday through Friday
  • Shipments dispatched throughout Canada
  • Discreet and secure packaging
  • Tracking provided with every shipment

Batch Documentation & Testing

Products are maintained under documented quality-control procedures to help ensure quality, consistency, and transparency.

  • HPLC purity analysis
  • Reference-standard comparison
  • Additional verification procedures (e.g. LC-MS confirmation) may be performed where warranted
  • Lot number traceability

Each product is assigned a unique lot number, allowing researchers to match their item directly to its corresponding Certificate of Analysis (COA).

Analytical Documentation

Supporting analytical documentation may be available for qualifying products, including batch-specific quality records and testing information.

Documentation may include:
  • Batch Number
  • Analytical Results
  • Traceability Records
  • Storage Information

RELATED PRODUCTS